Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisis.

Saved in:
Bibliographic Details
Title: Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisis.
Authors: Wang P; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Wu D; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Gong Z; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Adu-Gyamfi M; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Kamhieh-Milz J; Department of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., da Fonseca DLM; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Sürücü G; Department of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Ashraf MI; Department of Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany., Heidecke H; CellTrend GmbH, Luckenwalde, Germany., Sikorska D; Department of Rheumatology, Rehabilitation and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland., Cabral-Marques O; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil; Department of Medicine, Division of Molecular Medicine, Laboratory of Medical Investigation 29, University of São Paulo, Sao Paulo, SP, Brazil; Instituto D'Or de Ensino e Pesquisa, Sao Paulo, Brazil., Moll G; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany; BIH Center for Regenerative Therapies and Berlin-Brandenburg, School for Regenerative Therapies and Julius Wolff Institute, Charité Universitätsmedizin Berlin, Berlin, Germany., Riemekasten G; Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany., Witowski J; Department of Pathophysiology, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: jwitow@ump.edu.pl., Catar R; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: rusan.catar@charite.de.
Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2025 Apr; Vol. 273, pp. 110454. Date of Electronic Publication: 2025 Feb 14.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-7035
DOI:10.1016/j.clim.2025.110454